Effect of various concentrations of antibiotics on osteogenic cell viability and activity
Open Access
- 24 February 2011
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 29 (7), 1070-1074
- https://doi.org/10.1002/jor.21343
Abstract
Infection is a common complication of open fractures. Systemic antibiotics often cause adverse events before eradication of infected bone occurs. The local delivery of antibiotics and the use of implants that deliver both growth factors and antimicrobials are ways to circumvent systemic toxicity while decreasing infection and to reach extremely high levels required to treat bacterial biofilms. When choosing an antibiotic for a local delivery system, one should consider the effect that the antibiotic has on cell viability and osteogenic activity. To address this concern, osteoblasts were treated with 21 different antibiotics over 8 concentrations from 0 to 5,000 µg/ml. Osteoblast deoxyribonucleic acid content and alkaline phosphatase activity (ALP) were measured to determine cell number and osteogenic activity, respectively. Antibiotics that caused the greatest decrement include rifampin, minocycline, doxycycline, nafcillin, penicillin, ciprofloxacin, colistin methanesulfonate, and gentamicin; their cell number and ALP were significantly less than control at drug concentrations ≤200 µg/ml. Conversely, amikacin, tobramycin, and vancomycin were the least cytotoxic and did not appreciably affect cell number and ALP until very high concentrations were used. This comprehensive evaluation of numerous antibiotics' effects on osteoblast viability and activity will enable clinicians and researchers to choose the optimal antibiotic for treatment of infection and maintenance of healthy host bone. © 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 29: 1070–1074, 2011Keywords
This publication has 30 references indexed in Scilit:
- The Use of a Biodegradable, Load-Bearing Scaffold as a Carrier for Antibiotics in an Infected Open Fracture ModelJournal of Orthopaedic Trauma, 2010
- A Sustained Release of Lovastatin from Biodegradable, Elastomeric Polyurethane Scaffolds for Enhanced Bone RegenerationTissue Engineering, Part A, 2010
- Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: A preliminary study on cell responsesJournal of Orthopaedic Research, 2010
- Local Delivery of Tobramycin from Injectable Biodegradable Polyurethane ScaffoldsJournal of Biomaterials Science, Polymer Edition, 2010
- Complications Following Limb-Threatening Lower Extremity TraumaJournal of Orthopaedic Trauma, 2009
- Effects of cefuroxime on human osteoblasts in vitroJournal of Biomedical Materials Research Part A, 2007
- Influence on Mitochondria and Cytotoxicity of Different Antibiotics Administered in High Concentrations on Primary Human Osteoblasts and Cell LinesAntimicrobial Agents and Chemotherapy, 2007
- Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2Biomaterials, 2006
- Gentamicin negatively influenced osteogenic function in vitroInternational Orthopaedics, 2006
- The AminoglycosidesPublished by Ovid Technologies (Wolters Kluwer Health) ,1984